Glucuronide prodrugs of tofacitinib
where A1 and R1 are as defined. The invention also relates to pharmaceutical compositions comprising such compounds; methods of using such compounds to treat gastrointestinal inflammatory diseases; and processes and intermediates for preparing such compounds.
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English |
Published |
12.11.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!